Manchester Royal Infirmary
Manchester, M13 9WL, United Kingdom
NCT Number: NCT06858098
The goal of this clinical trial is to learn if a pre-operative outpatient exercise programme, monitored by a smart wearable device is acceptable to live kidney donor and recipient transplant patients. It will also look at the impact of prehabilitation on post operative outcomes. The main questions it aims to answer are:
Is it feasible for renal transplant patients and live kidney donors to participate in a prehabilitation programme in combination with a piece of wearable technology?
Are transplant outcomes improved by prehabilitation regimens delivered by video instruction?
Are there discernible perioperative digital signatures provided by the wearable that link to surgical outcomes?
Is the quality of perioperative sleep linked to surgical outcomes?
Participants will:
Wear a wrist or ring worn wearable device for a total of 14 weeks (2 week baseline, 6 week pre op and 6 week post op) Engage in a 6 week pre operative exercise programme at home/gym Keep a diary and answer surveys on their experience of the exercise regimen and wearable device
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Manchester, M13 9WL, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
6 week pre-operative graded prehabilitation programme, delivered by video and performed by participant up to 4 times a week at home or in a gym setting
Participants will wear a wearable smart device (wrist or ring worn) for a period for 14 weeks; 2 weeks prior to prehabilitation, 6 weeks during pre-operative prehabilitation and 6 weeks post operative monitoring,
Time frame: From enrollment to the end of the study at 14 weeks total
Acceptability of a prehabiltation programme and wearable device. Is a pre-operative exercise regimen, monitored by a wearable smart device acceptable to live kidney donor and recipient transplant patients? Qualitative data collected through patient surveys and journals. Quantitative measures = number of days exercise performed & number of days wearable device worn
Time frame: From enrollment to the end of the study at 14 weeks total - complications recorded at 6 week post op follow up
To assess if prehabilitation programmes have a positive effect on surgical outcomes, quantitative data on the rate and type of post operative complications will be recorded at the standard 6 week post operative patient follow up.
Time frame: From enrollment to the end of the study at 14 weeks total when data collection ends
To assess if there is a link between perioperative sleep patterns and post surgical complications, retrospective analysis of changes in REM vs Non-REM sleep patterns over the 14 week period will be compared to the incidence of post operative complications. REM vs. non-REM data is measured by the wearable device.
Time frame: From enrollment to the end of the study at 14 weeks total when data collection ends
Are there discernible perioperative digital signatures (vital signs) recorded by the wearable device that are linked to post-operative outcomes? Retrospective analysis of changes in resting heart rate and heart rate variability, both associated with physiological fitness, will be performed and compared to the incidence of post surgical complications in individual participants (outcome 2)
Contact information is provided by the study sponsor or research team.
Gareth Kitchen
CONTACT
Sophie Collinson
CONTACT
University of Manchester
Other
Outcomes of a Pre-operative Exercise Regimen for Patients Undergoing Hand-assisted Liver Donor Nephrectomy and Transplantation
Acronym: OPERATe
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07715734
Advanced Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma (CSCC)
St Louis, Missouri, United States
View Trial DetailsNCT07621835
CMV Reactivation, CMV Specific Immune Response
Córdoba, Spain
View Trial DetailsNCT00307125
Graft Function/Survival, Kidney Transplant
Birmingham, Alabama, United States
View Trial DetailsNCT07551531
Behavior, Kidney Transplant
Livingston, New Jersey, United States
View Trial Details